U.S. Markets closed

Pernix Therapeutics appoints Michael Pearce as President and CEO

The company announced that the Board of Directors has appointed Mike Pearce, Pernix’s Chairman of the Board, to President and CEO of Pernix. Pearce will also remain as Chairman of the Board, but will step down as a member of the company’s Audit Committee. Cooper Collins will remain on the Board of Directors and serve as the company’s Chief Strategic Officer.